Therapy: Off-label biologics use and infection risk-the great unknown

Kevin L. Winthrop; Josef S. Smolen

doi:10.1038/nrrheum.2011.154

Therapy: Off-label biologics use and infection risk-the great unknown

Kevin L. Winthrop, Josef S. Smolen

School Of Public Health

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	685-686
Number of pages	2
Journal	Nature Reviews Rheumatology
Volume	7
Issue number	12
DOIs	https://doi.org/10.1038/nrrheum.2011.154
State	Published - Dec 2011

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1038/nrrheum.2011.154

Cite this

@article{0c8e571c4cd640c2b7aa1fae75369f1f,

title = "Therapy: Off-label biologics use and infection risk-the great unknown",

author = "Winthrop, {Kevin L.} and Smolen, {Josef S.}",

year = "2011",

month = dec,

doi = "10.1038/nrrheum.2011.154",

language = "English (US)",

volume = "7",

pages = "685--686",

journal = "Nature Reviews Rheumatology",

issn = "1759-4790",

publisher = "Nature Publishing Group",

number = "12",

}

TY - JOUR

T1 - Therapy

T2 - Off-label biologics use and infection risk-the great unknown

AU - Winthrop, Kevin L.

AU - Smolen, Josef S.

PY - 2011/12

Y1 - 2011/12

UR - http://www.scopus.com/inward/record.url?scp=82955249018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82955249018&partnerID=8YFLogxK

U2 - 10.1038/nrrheum.2011.154

DO - 10.1038/nrrheum.2011.154

M3 - Article

C2 - 21989283

AN - SCOPUS:82955249018

SN - 1759-4790

VL - 7

SP - 685

EP - 686

JO - Nature Reviews Rheumatology

JF - Nature Reviews Rheumatology

IS - 12

ER -

Therapy: Off-label biologics use and infection risk-the great unknown

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this